MARKETS

BSE Prices delayed by 5 minutes... Prices as on Jan 18, 2019   ABB India 1275.6 [ -0.69% ]ACC 1439.95 [ -1.04% ]Ambuja Cements Ltd. 212.9 [ -1.02% ]Asian Paints Ltd. 1401.3 [ 0.85% ]Axis Bank Ltd. 664.3 [ -1.77% ]Bajaj Auto Ltd. 2716.55 [ -0.36% ]Bank of Baroda 117.95 [ -1.01% ]Bharti Airtel 310.95 [ -6.42% ]Bharat Heavy Ele 70.7 [ 0.86% ]Bharat Petroleum 353.5 [ -0.25% ]Britannia Ind. 3163.2 [ -1.19% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 509.7 [ -0.01% ]Coal India 230 [ -0.88% ]Colgate Palm. 1309.7 [ -1.10% ]Dabur India 424.05 [ 0.92% ]DLF Ltd. 180.3 [ -2.06% ]Dr. Reddy's Labs 2598.95 [ -0.68% ]GAIL (India) Ltd. 323.15 [ -2.84% ]Grasim Inds. 824 [ -0.52% ]HCL Technologies 964.5 [ 1.02% ]HDFC 2008.05 [ 0.19% ]HDFC Bank 2131.2 [ 0.10% ]Hero MotoCorp 2893 [ -0.46% ]Hindustan Unilever L 1743.7 [ -0.37% ]Hindalco Indus. 208.75 [ 1.36% ]ICICI Bank 371.9 [ -0.39% ]IDFC L 43.15 [ -1.03% ]Indian Hotels Co 136.75 [ -0.33% ]IndusInd Bank 1516.15 [ -0.41% ]Infosys 731 [ -0.33% ]ITC Ltd. 291.1 [ -0.95% ]Jindal St & Pwr 145.7 [ -0.21% ]Kotak Mahindra Bank 1237.35 [ 1.41% ]L&T 1318.25 [ -2.07% ]Lupin Ltd. 859.6 [ -1.00% ]Mahi. & Mahi 734.65 [ 0.05% ]Maruti Suzuki India 7353.35 [ 0.27% ]MTNL 14.9 [ -0.67% ]Nestle India 11241.05 [ 0.64% ]NIIT Ltd. 91 [ 2.65% ]NMDC Ltd. 90.7 [ -1.20% ]NTPC 144.35 [ -0.65% ]ONGC 146.25 [ 0.79% ]Punj. NationlBak 82.85 [ -1.78% ]Power Grid Corpo 193.25 [ -0.51% ]Reliance Inds. 1182.95 [ 4.34% ]SBI 295.2 [ -0.72% ]Vedanta 198.15 [ 0.43% ]Shipping Corpn. 44.6 [ -1.33% ]Sun Pharma. 390.75 [ -8.52% ]Tata Chemicals 692.75 [ -0.23% ]Tata Global Beverage 215.95 [ -1.30% ]Tata Motors Ltd. 183.1 [ -0.92% ]Tata Steel 470.5 [ -0.42% ]Tata Power Co. 76 [ 0.00% ]Tata Consultancy 1900.4 [ 0.28% ]Tech Mahindra Ltd. 707.7 [ 0.34% ]UltraTech Cement 3820.55 [ -0.82% ]United Spirits 584.6 [ -1.59% ]Wipro Ltd 346.2 [ 2.91% ]Zee Entertainment En 440.15 [ -0.19% ]

News Details

You can view in detail.
Cipla bags approval for Isoproterenol Hydrochloride Injection 14/06/2018 09:26

Cipla Limited (“Cipla”), has said that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single - use sterile Ampoule from the United States Food and Drug Administration (US FDA ).

Cipla’s Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is AP - rated generic therapeutic equivalent version of Hospira Inc’s Isuprel ® Injection, 0.2mg/m.

According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately USD 1 48 M for the 12-month period ending April 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Meanwhile, shares of the company were trading at Rs 589.30 apiece up 1.36 per cent from the previous close at 09:28 hrs on BSE.

LOAD MORE